JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics

  • 0The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
The Journal of Clinical Endocrinology and Metabolism +

|

May 27, 2024

|

May 27, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A new radiomics-clinical model using preoperative CT scans and clinical data accurately predicts radioactive iodine (131I) treatment efficacy in papillary thyroid cancer (PTC) patients, improving upon existing methods.

Area Of Science

  • Radiology
  • Oncology
  • Medical Imaging

Background

  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
  • Radioactive iodine (131I) therapy is a standard treatment for PTC after surgery.
  • Predicting the efficacy of initial 131I treatment is crucial for patient management.

Purpose Of The Study

  • To develop and validate a combined radiomics-clinical model for predicting 131I treatment efficacy in PTC.
  • To integrate preoperative computed tomography (CT) radiomics features with clinical data.
  • To assess the predictive performance of the combined model.

Main Methods

  • A cohort of 181 PTC patients undergoing total thyroidectomy and initial 131I treatment was analyzed.
  • Clinical factors were identified using univariate and multivariate logistic regression.
  • Radiomics features were extracted from preoperative CT scans and reduced using recursive feature elimination and LASSO.
  • A radiomics model, a clinical model, and a combined radiomics-clinical model were constructed and evaluated using AUC, sensitivity, and specificity.

Main Results

  • Pre-131I treatment serum thyroglobulin was a significant clinical predictor (AUC=0.895).
  • The radiomics model identified 14 key CT features and showed predictive performance (AUCs of 0.825 and 0.809 in training and testing sets).
  • The combined radiomics-clinical model demonstrated superior predictive performance compared to individual models.

Conclusions

  • Preoperative CT-based radiomics analysis can effectively predict 131I treatment efficacy in intermediate- to high-risk PTC.
  • The combined radiomics-clinical model offers enhanced predictive accuracy for 131I treatment outcomes.
  • This integrated approach aids in personalized treatment strategies for PTC.

Keywords: